Reducing the risk of stroke
through efficient and affordable
AF Screening

One Device.
One Solution.

The Zensor™ device is a complete system solution to allow you to measure and record a patient’s heart rhythm continuously for up 14 days. The extensive beat-by-beat data with optimal trace clarity, can provide critical insight, particularly with paroxysmal and intermittent incidents, to help improve patient outcomes.

Efficient and streamlined workflow

The simplicity of a single device incorporating both ambulatory ECG and event monitoring can help in streamlining the day-to-day workflow. Patient data can be directly uploaded to pre-set and customisable templates to produce time-saving and comprehensive reports, ready for consultation.

Cost-effective AF screening

As a reusable system, the Zensor™ device is associated with substantial savings compared to single-patient use devices. With the combined device and software package, patient screening becomes increasingly cost-effective with each subsequent use.

Full support and training

We will support you and your team every step of the way. Our dedicated team of clinical experts and customer support staff are there to help you incorporate the Zensor™ device into your practice so that you can diagnose your at-risk patients as quickly as possible.

Here are some of the support materials developed for you and your patients:

Compliance and Feedback

The patient-friendly Zensor™ device facilitates high patient compliance. With minimal setup and maintenance required by the patient, all the data you need will be collected and collated for you over a single monitoring period.

Clinician and patient feedback for the Zensor™ device has been overwhelmingly positive – here is a selection of the positive feedback we have received from both clinicians and patients.

Health professional and end-user feedback

Clinical

  • "Very useful for quick diagnosis"
  • "Patients have been positive about the experience"
  • "State of the art device, which is compact and easy to wear for the patients"
  • "Easy to use for clinical staff and patients"

Patient

  • "A very positive and quick way to be diagnosed"
  • "After a day or two I did not notice wearing it"
  • "I felt confident using the Zensor™ device"
  • "The device was fine to wear, forgot it was on most of the time"
  • "It is a good idea to have a device which you can use in real time"

Clinician and patient feedback disclosed was captured as part of a Zensor™ device evaluation at South Eastern Health and Social Care Trust, Northern Ireland and a Stroke Prevention study.

Clinical Evidence

Supporting Zensor™ device

The Zensor™ device has been used to date in hundreds of patients in Europe and the US. At Tallaght University Hospital, Dublin, Ireland, a study was undertaken to identify high risk patients with AF. The device was proven to deliver an effective, convenient and reliable method of diagnosing AF in a high risk population.